Issue 2/2020
Content (29 Articles)
Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach
Abass Alavi, Jorge R. Barrio, Thomas J. Werner, Mohsen Khosravi, Andrew Newberg, Poul Flemming Høilund-Carlsen
A future for PET imaging in Alzheimer’s disease
Aurélie Kas, Raffaella Migliaccio, Bertrand Tavitian
Age-associated reorganization of metabolic brain connectivity in Chinese children
Qi Huang, Jian Zhang, Tianhao Zhang, Hui Wang, Jianhua Yan
The A/T/N model applied through imaging biomarkers in a memory clinic
Alessandra Dodich, Aline Mendes, Frédéric Assal, Christian Chicherio, Barinjaka Rakotomiaramanana, Paulina Andryszak, Cristina Festari, Federica Ribaldi, Max Scheffler, Roger Schibli, Adam J. Schwarz, Dina Zekry, Karl-Olof Lövblad, Marina Boccardi, Paul G. Unschuld, Gabriel Gold, Giovanni B. Frisoni, Valentina Garibotto
Brain metabolic signatures across the Alzheimer’s disease spectrum
Arianna Sala, Camilla Caprioglio, Roberto Santangelo, Emilia Giovanna Vanoli, Sandro Iannaccone, Giuseppe Magnani, Daniela Perani
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
Matteo Cotta Ramusino, Valentina Garibotto, Ruggero Bacchin, Daniele Altomare, Alessandra Dodich, Frederic Assal, Aline Mendes, Alfredo Costa, Michele Tinazzi, Silvia D. Morbelli, Matteo Bauckneht, Agnese Picco, Massimo E. Dottorini, Cristina Tranfaglia, Lucia Farotti, Nicola Salvadori, Davide Moretti, Giordano Savelli, Anna Tarallo, Flavio Nobili, Maura Parapini, Carlo Cavaliere, Elena Salvatore, Marco Salvatore, Marina Boccardi, Giovanni B Frisoni
Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment
Virgile Clergue-Duval, Frank Questel, Julien Azuar, Claire Paquet, Emmanuel Cognat, Jihed Amami, Mathieu Queneau, Alexandra Dereux, Thomas Barré, Frank Bellivier, Karim Farid, Florence Vorspan
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients
Hyemin Jang, Hee Jin Kim, Seongbeom Park, Yu Hyun Park, Yeongsim Choe, Hanna Cho, Chul Hyoung Lyoo, Uicheul Yoon, Jin San Lee, Yeshin Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Young Hoon Ryu, Jae Yong Choi, Seung Hwan Moon, Joon-Kyung Seong, Charles DeCarli, Michael W. Weiner, Samuel N. Lockhart, Soo Hyun Cho, Duk L. Na, Sang Won Seo
Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer’s disease
Matthieu Vanhoutte, Franck Semah, Xavier Leclerc, Adeline Rollin Sillaire, Alice Jaillard, Grégory Kuchcinski, Xavier Delbeuck, Rachid Fahmi, Florence Pasquier, Renaud Lopes
Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease
Tomotaka Tanaka, Mary C. Stephenson, Ying-Hwey Nai, Damian Khor, Francis N. Saridin, Saima Hilal, Steven Villaraza, Bibek Gyanwali, Masafumi Ihara, Henri Vrooman, Ashley A. Weekes, John J. Totman, Edward G. Robins, Christopher P. Chen, Anthonin Reilhac
The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases
Hye Joo Son, Jungsu S. Oh, Minyoung Oh, Soo Jong Kim, Jae-Hong Lee, Jee Hoon Roh, Jae Seung Kim
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
Ruben Smith, Michael Schöll, Antoine Leuzy, Jonas Jögi, Tomas Ohlsson, Olof Strandberg, Oskar Hansson
Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain
Vasko Kramer, Agnete Dyssegaard, Jonathan Flores, Cristian Soza-Ried, Frank Rösch, Gitte Moos Knudsen, Horacio Amaral, Matthias M. Herth
[18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
Antonio Carotenuto, Beniamino Giordano, George Dervenoulas, Heather Wilson, Mattia Veronese, Zachary Chappell, Sotirios Polychronis, Gennaro Pagano, Jane Mackewn, Federico E. Turkheimer, Steven C. R. Williams, Alexander Hammers, Eli Silber, Peter Brex, Marios Politis
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
Marloes H. J. Hagens, Sandeep S. V. Golla, Bieneke Janssen, Danielle J. Vugts, Wissam Beaino, Albert D. Windhorst, James O’Brien-Brown, Michael Kassiou, Robert C. Schuit, Lothar A. Schwarte, Helga E. de Vries, Joep Killestein, Frederik Barkhof, Bart N. M. van Berckel, Adriaan A. Lammertsma
In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
Christine Bastin, Mohamed Ali Bahri, François Meyer, Marine Manard, Emma Delhaye, Alain Plenevaux, Guillaume Becker, Alain Seret, Christine Mella, Fabrice Giacomelli, Christian Degueldre, Evelyne Balteau, André Luxen, Eric Salmon
Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer’s disease to Parkinson’s disease
Hongyoon Choi, Yu Kyeong Kim, Eun Jin Yoon, Jee-Young Lee, Dong Soo Lee
From metabolic connectivity to molecular connectivity: application to dopaminergic pathways
Antoine Verger, Tatiana Horowitz, Mohammad B. Chawki, Alexandre Eusebio, Manon Bordonne, Jean-Philippe Azulay, Nadine Girard, Eric Guedj
Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson’s disease: a hybrid PET/MR study of resting-state brain metabolism
Rafael Rodriguez-Rojas, Jose A. Pineda-Pardo, Raul Martinez-Fernandez, Rosalie V. Kogan, Carlos A. Sanchez-Catasus, Marta del Alamo, Frida Hernández, Lina García-Cañamaque, Klaus L. Leenders, Jose A. Obeso
Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
Sanne K. Meles, Remco J. Renken, Marco Pagani, L. K. Teune, Dario Arnaldi, Silvia Morbelli, Flavio Nobili, Teus van Laar, Jose A. Obeso, Maria C. Rodríguez-Oroz, Klaus L. Leenders
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
Stuart P. McCluskey, Christophe Plisson, Eugenii A. Rabiner, Oliver Howes
Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB
Sylvain Auvity, Matteo Tonietto, Fabien Caillé, Benedetta Bodini, Michel Bottlaender, Nicolas Tournier, Bertrand Kuhnast, Bruno Stankoff
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
Granville James Matheson, Pontus Plavén-Sigray, Jouni Tuisku, Juha Rinne, David Matuskey, Simon Cervenka
Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET”
René Raavé, Gerwin Sandker, Pierre Adumeau, Christian Borch Jacobsen, Floriane Mangin, Michel Meyer, Mathieu Moreau, Claire Bernhard, Laurène Da Costa, Adrien Dubois, Victor Goncalves, Magnus Gustafsson, Mark Rijpkema, Otto Boerman, Jean-Claude Chambron, Sandra Heskamp, Franck Denat
EANM Springer Prizes awarded at EANM’ 19 Barcelona
The tail of the striatum uncovered by FP-CIT PET in isolated striatocapsular infarct
Chanwoo Kim
Striking neurologic 18F-FDG PET/CT pattern in Devic’s disease (neuromyelitis optica spectrum disorder)
Diego Alfonso López-Mora, Albert Flotats, Alejandro Fernández, Marina Sizova, Valle Camacho, Ignasi Carrió
Publisher Correction: Artificial intelligence and radiomics in nuclear medicine: potentials and challenges
Cumali Aktolun
Correction to: Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy
Jolanta Kunikowska, Bartosz Królicki, Leszek Królicki